Schrodinger Inc Ordinary Shares SDGR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law Firm
-
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
-
Schrödinger Reports Strong Second Quarter 2024 Financial Results
-
Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology
-
Schrödinger to Announce Second Quarter 2024 Financial Results on July 31
-
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Trading Information
- Previous Close Price
- $17.44
- Day Range
- $17.46–18.12
- 52-Week Range
- $17.15–38.00
- Bid/Ask
- $17.43 / $17.70
- Market Cap
- $1.27 Bil
- Volume/Avg
- 812,627 / 634,063
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.43
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 787
- Website
- https://www.schrodinger.com
Comparables
Valuation
|
Metric
|
SDGR
|
RXRX
|
688062
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.68 | 2.91 | 5.09 |
Price/Sales | 6.43 | 28.41 | 71.82 |
Price/Cash Flow | — | — | — |
Price/Earnings
SDGR
RXRX
688062
Financial Strength
|
Metric
|
SDGR
|
RXRX
|
688062
|
|---|---|---|---|
Quick Ratio | 4.30 | 5.54 | 1.53 |
Current Ratio | 4.50 | 6.07 | 1.78 |
Interest Coverage | — | −852.98 | −32.55 |
Quick Ratio
SDGR
RXRX
688062
Profitability
|
Metric
|
SDGR
|
RXRX
|
688062
|
|---|---|---|---|
Return on Assets (Normalized) | −23.79% | −47.23% | −24.26% |
Return on Equity (Normalized) | −33.92% | −65.86% | −41.90% |
Return on Invested Capital (Normalized) | −27.54% | −61.55% | −26.98% |
Return on Assets
SDGR
RXRX
688062
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock
GEHC
| Zwrvfyk | Ylxw | $41.0 Bil | |||
| Veeva Systems Inc Class A
VEEV
| Lqzlvtxjl | Vgwz | $33.1 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Xbvjtry | $12.8 Bil | |||
| Solventum Corp
SOLV
| — | Vqvwfst | $11.6 Bil | |||
| Doximity Inc Class A
DOCS
| — | Ztjr | $8.1 Bil | |||
| Tempus AI Inc Class A common stock
TEM
| — | Djdkh | $7.6 Bil | |||
| M3 Inc
MTHRF
| — | Crlcqy | $7.4 Bil | |||
| M3 Inc ADR
MTHRY
| — | Mdlzd | $7.4 Bil | |||
| HealthEquity Inc
HQY
| — | Tjrvb | $6.8 Bil | |||
| R1 RCM Inc
RCM
| — | Csd | $6.0 Bil |
United States